Elizabeth A. Barrett's Net Worth
Elizabeth A. Barrett has an <strong>estimated net worth of $4.73 Million dollars</strong>. This is based on reported shares across multiple companies, which include UroGen Pharma Ltd., Allogene Therapeutics, Inc., and Lifesci Acquisition II Corp..<br /><br />Elizabeth A. Barrett owns<strong>326,691 shares</strong> of UroGen Pharma Ltd.'s Ordinary Shares which is worth $4,818,692.25 dollars. From 2019 to 2023 Elizabeth A. Barrett acquired a total of <strong>482,160 shares in UroGen Pharma Ltd.</strong> at a cost of $645 Thousand, Elizabeth also disposed a total of <strong>58,588 shares of UroGen Pharma Ltd.</strong> equalling $552 Thousand.
Estimate Recalculated Apr 24, 2024 03:20PM EST
Who is Elizabeth A. Barrett?
SEC CIK
Elizabeth A. Barrett's CIK is 0001764157
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
UroGen Pharma Ltd. (URGN) No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
| +5.95% | 18.33K |
—
|
—
| 326.69K |
Jan 31
| |||
Form 4
| +3.40% | 10.14K |
$7.58 | -$62,118.10 | 308.36K |
Jan 31
| |||
Form 4
| +24.52% | 58.72K |
$9.15 | -$429,757.20 | 298.22K |
Jan 3 - Jan 4
| |||
Form 4/A
| +39.15% | 61.65K |
—
|
—
| 219.12K |
Jun 3 - Dec 3
| |||
Form 4/A
| +28.82% | 35.23K |
—
|
—
| 157.47K |
Feb 3 - May 3
| |||
Form 4
| +4.53% | 10.38K |
$17.51 | -$59,967.98 | 239.5K |
Jan 3 - May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
| +4.56% | 10K |
$18.50 | $185,000.00 | 229.12K |
Dec 14
| |||
Form 4
| +39.15% | 61.65K |
—
|
—
| 219.12K |
Dec 4
| |||
Form 4
| +28.82% | 35.23K |
—
|
—
| 157.47K |
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
| +638.68% | 105.69K |
—
|
—
| 122.24K |
Jan 3
| |||
Form 4
| +83.50% | 7.53K |
$28.00 | $210,840.00 | 16.55K |
Nov 21
| |||
Form 4
| +482.56% | 7.47K |
$28.00 | $209,160.00 | 9.02K |
Nov 20
| |||
Form 4
|
∞
| 1.55K |
$26.00 | $40,248.00 | 1.55K |
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Allogene Therapeutics, Inc. (ALLO) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lifesci Acquisition II Corp. (SNCE) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||